| Three Induction Treatments on Cryptococcal Meningitis (NCT04072640) | First Affiliated Hospital of Zhejiang University | 2021-01-25 |
| Clinical Effectiveness and Safety of Amphotericin B With Flucytosine-Fluconazole Therapy for Cryptococcal Meningitis (NCT04532463) | University of Pharmacy, Yangon | 2020-10-01 |
| The Lived Experience of Participants in an African Randomised Trial (NCT04296292) | London School of Hygiene and Tropical Medicine | 2020-02-05 |
| AmB Dose for Cryptococcal Meningitis (NCT04140461) | Shanghai Public Health Clinical Center | 2020-01-02 |
| Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT) (NCT04031833) | Matinas BioPharma Nanotechnologies, Inc. | 2019-10-24 |
| Driving Reduced AIDS-associated Meningo-encephalitis Mortality (NCT03226379) | St George's, University of London | 2016-04-23 |
| Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis (NCT02686853) | Hui Bu | 2016-01-01 |
| Vietnam Cryptococcal Retention in Care Study - Version 2.1 (NCT03267407) | National Hospital for Tropical Diseases, Hanoi, Vietnam | 2015-08-14 |
| Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS (NCT02624453) | ANRS, Emerging Infectious Diseases | 2015-07-01 |
| Vietnam Cryptococcal Retention in Care Study (CRICS) Federal Financial Report (NCT02955862) | National Hospital for Tropical Diseases, Hanoi, Vietnam | 2015-06-01 |
| CryptoART Study: Decreasing Mortality Associated With Initiation of Antiretroviral Therapy in Sub-Saharan Africa (NCT02434172) | University of Zimbabwe | 2015-04-01 |
| Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis (NCT01802385) | University of Minnesota | 2015-03-09 |
| Clinical Outcomes of Cryptococcal Meningitis Among HIV-infected Patients in the Era of Antiretroviral Therapy (NCT02098525) | Mahidol University | 2013-11-01 |
| Operational Research for Cryptococcal Antigen Screening (NCT01535469) | University of Minnesota | 2012-07-01 |
| Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa (NCT01715922) | ANRS, Emerging Infectious Diseases | 2012-05-01 |
| Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis (NCT02136030) | TTY Biopharm | 2011-02-01 |
| Cryptococcal Optimal ART Timing Trial (NCT01075152) | University of Minnesota | 2010-11-01 |
| High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals (NCT00885703) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-04-16 |
| Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia (NCT00867269) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-07-13 |
| Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS (NCT00324025) | Novartis Pharmaceuticals | 2007-03-01 |
| Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa (NCT00830856) | University of Zimbabwe | 2006-10-01 |
| Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS (NCT00847678) | Novartis Pharmaceuticals | 2006-08-01 |
| Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis (NCT00145249) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-05-01 |
| Fungal Infection Susceptibility (NCT00001352) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-04-01 |